期刊文献+

他汀类药物在心力衰竭治疗中的作用 被引量:9

下载PDF
导出
摘要 近来多项研究表明.冠状动脉粥样硬化性疾病(冠心病)已经成为威胁人类健康的重要疾病之一,而血脂异常是冠心病的重要危险因素,因此,调脂治疗成为防治冠心病的最重要手段。目前临床上广泛应用他汀类药物来降脂治疗,疗效显著。他汀类药物除有明显的降脂作用外,还有稳定斑块,改善炎症,降低血小板聚集等非降脂作用。更有报告他汀类药物可阻止心力衰竭的发展而减少心衰患者的冠脉事件。
作者 王英洁
机构地区 沈阳市
出处 《心血管康复医学杂志》 CAS 2006年第1期84-85,96,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
  • 相关文献

参考文献10

  • 1Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J]. N Engl J Med, 1996,335 (14) : 1001.
  • 2The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients With coronary heart disease and a broad range of initial cholesterol levels [J]. N Engl J Med, 1998,339 (19): 1349-1357.
  • 3高金库,何书静,张明.强化降脂对急性冠脉综合征PCI患者远期疗效的影响[J].心血管康复医学杂志,2005,14(3):219-219. 被引量:4
  • 4Rosenson RS, Tangney CE, Casev LC, et al. Inhibition of proinflammatory cytokine production by pravastatin [J]. Lancet, 1999, 353 (9157):983-984.
  • 5Pehlivanidis AN, Athyros VG, Demitriadis DS, et al. Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease [J]. Atherosclerosis, 2001, 157 (2):463-469.
  • 6Strehlow K, Wassmann S, Bohm M, et al, Angiotensin AT1 receptor over-expression in hypercholesterolaemia [J], Ann Med, 2000, 32 (6): 386-389.
  • 7Niwa S, Totsuka T, Hayashi S. Inhibitory effect of fluvastatin, an HMG-CoA reduetase inhibitor, on the expression of adhesion molecules on human monoeyte cell line [J]. Int J Immunopharmacol, 1996, 18 (11):669-675.
  • 8Lacoste L, Lam JY, Hung J, et al. Hyperlipidemia and coronary disease: Correction of the increased thrombogenic potential with cholesterol reduction[J]. Circulation, 1995, 92 (11) : 3172-3177.
  • 9Waiter DH, Schachinger V, Eisner M, et al. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the P1A2 allele of the platelet glycoprotein lagene [J]. Eur Heart J, 2001, 22 (7):587-595.
  • 10Hayashidani S, Tsutsui H, Shiomi T, et al. Fliavastatin, a 3-Hydroxy-3-Methylglutaryl coenzyme a reduetase inhibitor, attenuates left ventrieular remodeling and failure after experimental myocardial infarction [J]. Circulation, 2002, 105 (7): 868-873.

共引文献3

同被引文献67

  • 1金争鸣,胡晓晟,陈君柱,胡申江,张芙荣.慢性心力衰竭患者早期肾损害的临床研究[J].中华内科杂志,2005,44(4):262-264. 被引量:42
  • 2胡大一,吴彦.规范心力衰竭治疗 加强患者管理[J].中华心血管病杂志,2005,33(6):495-497. 被引量:124
  • 3涂春莲,陈伟,周明成,王莹,许其倓.他汀类药物短期治疗慢性心衰对心功能和细胞因子影响的临床观察[J].实用诊断与治疗杂志,2005,19(8):572-573. 被引量:11
  • 4徐淑云,卞如廉,陈修.药理学实验方法[M].第三版.北京:人民卫生出版社,2002:1204-1206.
  • 5Nguyen SD, Sok DE. Oxidative inactivation of paraoxonasel, an antioxidant-protein and its effect on antioxidant action [J]. Free RadiaRes, 2003, 37 (12): 1319-1330.
  • 6Mougenot N, Lesnik P, Nataf P, et al. Effect of the oxidation state of LDL on the modulation of arterial vasometer reponse in vitro [J]. Atherosclerosis, 1997, 133 (2): 183-185.
  • 7Watanabe T, Pakala R, Koba S, et al. Lysophosphatiedcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular amooth muscle cell proliferation [J]. Circulation, 2001, 103 (10): 1440-1445.
  • 8曾定尹.心力衰竭[M]//王吉耀,内科学(8年制教材).北京:人民卫生出版社.2005:187.
  • 9Grundy SM. HMG-coA reductase inhibitors for treatment of hypercholesterolemia [J]. N Engl J Med, 1998, 319: 24- 33.
  • 10Shepherd J, Cobbe SM, Ford I, et al. For the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hyper- cholesterolemia[J]. N Engl J Med, 1995, 33:1 301- 307.

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部